![](https://investorshub.advfn.com/uicon/40536.png?cb=1561902029)
Wednesday, May 15, 2019 7:54:37 AM
My belief in the summer, which is just a few weeks away, is all the additional doctors we will see. Based only on how the tide has turned, I think we see Sanderson trained and up and running late this month. I think we see OH, TN, TX announced and trained and treating in June, along with an unknown amount that are calling and showing interest.
Like Dr Said’s, Narayan’s and Liu’s videos, this treatment fits the gap between risky drugs, and surgery. As word spreads in the medical community the doctors interested in using CaverStem and FemCelz will multiply quickly. I fully expect to see the same thing occur in Europe and likely across the Middle East and Asia for all the same reasons. Like NSX said, the Rome info was huge, very telling, backed by the Italian Ministry of Health. Imagine that backing in the USA?
When those things all align in the next several weeks everything will change here. This will go from a vastly unknown company and stock with few views on social media, to thousand and thousands of views and likes.
Adding fuel to the fire, and having the infrastructure set, CELZ will have the revs to kick in a more traditional marketing campaign and we will see the TV commercials and more IMO.
DD will tell you that the recovery time has been sufficient for the early on treated patients and the patient testimonials that we verified are being tapes will be out.
I am not sure how you can look at all of those things that are in black and white and not think buying in below .05 is a no brainer, let alone this ridiculous sub penny range.
The OTC is full of companies with less revs, worse SS that trade in the quarters. When the right folks see that here, hold on!!!!
All of this gets followed up by StemSpine then an encore with AmnioStem. I am buying all I can, locking and loaded for the foreseeable future. But, that is just me.
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM